Multifaceted roles of glycolytic enzymes

Trends in Biochemical Sciences

Volumn 30, Issue 3, 2005, Pages 142-150

  Kim, Jung Whan ^a   Dang, Chi V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOLASE; GLUCOKINASE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEXOKINASE; ISOENZYME; LACTATE DEHYDROGENASE;

APOPTOSIS; CELL MOTILITY; ENZYME ACTIVITY; GLYCOLYSIS; METABOLISM; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SENSOR; TRANSCRIPTION REGULATION;

EID: 14744284637     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2005.01.005     Document Type: Review

References (93)

1. B. Canback The global phylogeny of glycolytic enzymes Proc. Natl. Acad. Sci. U. S. A. 99 2002 6097 6102
2. L. Poellinger, and R.S. Johnson HIF-1 and hypoxic response: the plot thickens Curr. Opin. Genet. Dev. 14 2004 81 85
3. C.J. Schofield, and P.J. Ratcliffe Oxygen sensing by HIF hydroxylases Nat. Rev. Mol. Cell Biol. 5 2004 343 354
4. M. Ohh Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein Nat. Cell Biol. 2 2000 423 427
5. W. Krek VHL takes HIF's breath away Nat. Cell Biol. 2 2000 E121 E123
6. 2-regulated prolyl hydroxylation Science 292 2001 468 472
7. G.L. Semenza Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1 J. Biol. Chem. 271 1996 32529 32537
8. G.L. Semenza Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1 J. Biol. Chem. 269 1994 23757 23763
9. O. Warburg On the origin of cancer cells Science 123 1956 309 314
10. C.V. Dang, and G.L. Semenza Oncogenic alterations of metabolism Trends Biochem. Sci. 24 1999 68 72
11. R.L. Elstrom Akt stimulates aerobic glycolysis in cancer cells Cancer Res. 64 2004 3892 3899
12. J.W. Kim Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays Mol. Cell. Biol. 24 2004 5923 5936
13. R.E. Barry, and W. Krek The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis Trends Mol. Med. 10 2004 466 472
14. S. Kaptain A regulated RNA binding protein also possesses aconitase activity Proc. Natl. Acad. Sci. U. S. A. 88 1991 10109 10113
15. T.A. Rouault Structural relationship between an iron-regulated RNA-binding protein (IRE-BP) and aconitase: functional implications Cell 64 1991 881 883
16. D.A. Hall Regulation of gene expression by a metabolic enzyme Science 306 2004 482 484
17. R.J. Trumbly Glucose repression in the yeast Saccharomyces cerevisiae Mol. Microbiol. 6 1992 15 21
18. J.A. Diderich Physiological properties of Saccharomyces cerevisiae from which hexokinase II has been deleted Appl. Environ. Microbiol. 67 2001 1587 1593
19. P. Herrero Identification and characterisation of two transcriptional repressor elements within the coding sequence of the Saccharomyces cerevisiae HXK2 gene Nucleic Acids Res. 24 1996 1822 1828
20. P. Herrero Transcriptional regulation of the Saccharomyces cerevisiae HXK1, HXK2 and GLK1 genes Yeast 11 1995 137 144
21. D. Niederacher, and K.D. Entian Characterization of Hex2 protein, a negative regulatory element necessary for glucose repression in yeast Eur. J. Biochem. 200 1991 311 319
22. A. Rodriguez The hexokinase 2 protein regulates the expression of the GLK1, HXK1 and HXK2 genes of Saccharomyces cerevisiae Biochem. J. 355 2001 625 631
23. P. Herrero The hexokinase 2 protein participates in regulatory DNA-protein complexes necessary for glucose repression of the SUC2 gene in Saccharomyces cerevisiae FEBS Lett. 434 1998 71 76
24. D. Ahuatzi The glucose-regulated nuclear localization of hexokinase 2 in Saccharomyces cerevisiae is Mig1-dependent J. Biol. Chem. 279 2004 14440 14446
25. T. de la Cera Mediator factor Med8p interacts with the hexokinase 2: implication in the glucose signalling pathway of Saccharomyces cerevisiae J. Mol. Biol. 319 2002 703 714
26. R. Jiang, and M. Carlson Glucose regulates protein interactions within the yeast SNF1 protein kinase complex Genes Dev. 10 1996 3105 3115
27. O. Vincent Subcellular localization of the Snf1 kinase is regulated by specific β subunits and a novel glucose signaling mechanism Genes Dev. 15 2001 1104 1114
28. P. Sanz Regulatory interactions between the Reg1-Glc7 protein phosphatase and the Snf1 protein kinase Mol. Cell. Biol. 20 2000 1321 1328
29. A. Cattaneo Nuclear localization of a lactic dehydrogenase with single-stranded DNA-binding properties Exp. Cell Res. 161 1985 130 140
30. F. Grosse Lactate dehydrogenase and glyceraldehyde-phosphate dehydrogenase are single-stranded DNA-binding proteins that affect the DNA-polymerase-α-primase complex Eur. J. Biochem. 160 1986 459 467
31. K.R. Williams Identification of a nucleic acid helix-destabilizing protein from rat liver as lactate dehydrogenase-5 Proc. Natl. Acad. Sci. U. S. A. 82 1985 5260 5264
32. L. Zheng S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component Cell 114 2003 255 266
33. J.A. Cooper Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro J. Biol. Chem. 259 1984 7835 7841
34. N. Reiss Five enzymes of the glycolytic pathway serve as substrates for purified epidermal-growth-factor-receptor kinase Biochem. J. 239 1986 691 697
35. X.H. Zhong, and B.D. Howard Phosphotyrosine-containing lactate dehydrogenase is restricted to the nuclei of PC12 pheochromocytoma cells Mol. Cell. Biol. 10 1990 770 776
36. E. Nagy Identification of the NAD(+)-binding fold of glyceraldehyde-3- phosphate dehydrogenase as a novel RNA-binding domain Biochem. Biophys. Res. Commun. 275 2000 253 260
37. M. Perucho Study of the interaction of glyceraldehyde-3-phosphate dehydrogenase with DNA Biochim. Biophys. Acta 606 1980 181 195
38. M.A. Sirover New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase Biochim. Biophys. Acta 1432 1999 159 184
39. K.P. Sundararaj Rapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase J. Biol. Chem. 279 2004 6152 6162
40. S. Choudhary Specific phosphorylated forms of glyceraldehyde 3-phosphate dehydrogenase associate with human parainfluenza virus type 3 and inhibit viral transcription in vitro J. Virol. 74 2000 3634 3641
41. B.P. De Specific interaction in vitro and in vivo of glyceraldehyde-3- phosphate dehydrogenase and LA protein with cis-acting RNAs of human parainfluenza virus type 3 J. Biol. Chem. 271 1996 24728 24735
42. G. Dollenmaier, and M. Weitz Interaction of glyceraldehyde-3-phosphate dehydrogenase with secondary and tertiary RNA structural elements of the hepatitis A virus 3′ translated and non-translated regions J. Gen. Virol. 84 2003 403 414
43. D.E. Schultz Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5′-nontranslated RNA of hepatitis A virus J. Biol. Chem. 271 1996 14134 14142
44. M. Sioud, and L. Jespersen Enhancement of hammerhead ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase J. Mol. Biol. 257 1996 775 789
45. P.A. Pioli Lactate dehydrogenase is an AU-rich element-binding protein that directly interacts with AUF1 J. Biol. Chem. 277 2002 35738 35745
46. E. Nagy, and W.F. Rigby Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold) J. Biol. Chem. 270 1995 2755 2763
47. M.A. Sirover Minireview. Emerging new functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells Life Sci. 58 1996 2271 2277
48. M.A. Sirover Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology J. Cell. Biochem. 66 1997 133 140
49. R.B. Ray Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice Cancer Res. 55 1995 3747 3751
50. A.K. Ghosh Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation Mol. Cell. Biol. 19 1999 2880 2886
51. A. Subramanian, and D.M. Miller Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene J. Biol. Chem. 275 2000 5958 5965
52. A.K. Ghosh MBP-1 physically associates with histone deacetylase for transcriptional repression Biochem. Biophys. Res. Commun. 260 1999 405 409
53. A.K. Ghosh A novel 16-kilodalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1 Mol. Cell. Biol. 21 2001 655 662
54. S. Feo ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1) FEBS Lett. 473 2000 47 52
55. Y.S. Chang Enolase-α is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior Clin. Cancer Res. 9 2003 3641 3644
56. H. Lee LOS2, a genetic locus required for cold-responsive gene transcription encodes a bi-functional enolase EMBO J. 21 2002 2692 2702
57. T. Ogino Enolase, a cellular glycolytic enzyme, is required for efficient transcription of Sendai virus genome Biochem. Biophys. Res. Commun. 285 2001 447 455
58. K.K. Arora Glucose phosphorylation in tumor cells. Cloning, sequencing, and overexpression in active form of a full-length cDNA encoding a mitochondrial bindable form of hexokinase J. Biol. Chem. 265 1990 6481 6488
59. A. Rempel Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase Cancer Res. 56 1996 2468 2471
60. S.G. Golshani-Hebroni, and S.P. Bessman Hexokinase binding to mitochondria: a basis for proliferative energy metabolism J. Bioenerg. Biomembr. 29 1997 331 338
61. J.G. Pastorino, and J.B. Hoek Hexokinase II: the integration of energy metabolism and control of apoptosis Curr. Med. Chem. 10 2003 1535 1551
62. J.M. Bryson Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death J. Biol. Chem. 277 2002 11392 11400
63. K. Gottlob Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase Genes Dev. 15 2001 1406 1418
64. N. Majewski Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases Mol. Cell. Biol. 24 2004 730 740
65. J.G. Pastorino Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis J. Biol. Chem. 277 2002 7610 7618
66. J.C. Rathmell Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival Mol. Cell. Biol. 23 2003 7315 7328
67. N.N. Danial BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis Nature 424 2003 952 956
68. P.A. Saunders Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis J. Neurochem. 72 1999 925 932
69. R. Ishitani, and D.M. Chuang Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside- induced apoptosis in cultured cerebellar neurons Proc. Natl. Acad. Sci. U. S. A. 93 1996 9937 9941
70. H. Tajima Over-expression of GAPDH induces apoptosis in COS-7 cells transfected with cloned GAPDH cDNAs Neuroreport 10 1999 2029 2033
71. Z. Dastoor, and J.L. Dreyer Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress J. Cell Sci. 114 2001 1643 1653
72. P. Shashidharan Nuclear translocation of GAPDH-GFP fusion protein during apoptosis Neuroreport 10 1999 1149 1153
73. J.L. Mazzola, and M.A. Sirover Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts J. Neurochem. 76 2001 442 449
74. V.M. Brown A novel CRM1-mediated nuclear export signal governs nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase following genotoxic stress J. Biol. Chem. 279 2004 5984 5992
75. E. Kragten Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl J. Biol. Chem. 273 1998 5821 5828
76. E.Y. Krynetski A nuclear protein complex containing high mobility group proteins B1 and B2, heat shock cognate protein 70, ERp60, and glyceraldehyde-3-phosphate dehydrogenase is involved in the cytotoxic response to DNA modified by incorporation of anticancer nucleoside analogues Cancer Res. 63 2003 100 106
77. C. Xing Identification of GAPDH as a protein target of the saframycin antiproliferative agents Proc. Natl. Acad. Sci. U. S. A. 101 2004 5862 5866
78. J.L. Mazzola, and M.A. Sirover Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblasts J. Neurosci. Res. 71 2003 279 285
79. A.J. Cooper Glyceraldehyde 3-phosphate dehydrogenase abnormality in metabolically stressed Huntington disease fibroblasts Dev. Neurosci. 20 1998 462 468
80. Y.J. Sun The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin Proc. Natl. Acad. Sci. U. S. A. 96 1999 5412 5417
81. L.A. Liotta Tumor cell autocrine motility factor Proc. Natl. Acad. Sci. U. S. A. 83 1986 3302 3306
82. Y. Niinaka Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells Cancer Res. 58 1998 2667 2674
83. I.R. Nabi Identification of B16-F1 melanoma autocrine motility-like factor receptor Cancer Res. 50 1990 409 414
84. Y. Hirono Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer Br. J. Cancer 74 1996 2003 2007
85. S. Tsutsumi Overexpression of the autocrine motility factor/ phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts Cancer Res. 63 2003 242 249
86. S. Silletti Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants Cancer Res. 54 1994 5752 5756
87. J. Timar Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events Clin. Exp. Metastasis 17 1999 809 816
88. T. Torimura Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins Hepatology 34 2001 62 71
89. S. Tsutsumi Activation of small GTPase Rho is required for autocrine motility factor signaling Cancer Res. 62 2002 4484 4490
90. S. Mishra Insulin-like growth factor binding protein-3 interacts with autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and inhibits the AMF/PGI function Cancer Res. 64 2004 2516 2522
91. S. Tsutsumi The enzymatic activity of phosphoglucose isomerase is not required for its cytokine function FEBS Lett. 534 2003 49 53
92. L.C. Schulz, and J.M. Bahr Potential endocrine function of the glycolytic enzyme glucose-6-phosphate isomerase during implantation Gen. Comp. Endocrinol. 137 2004 283 287
93. H. Watanabe Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide Cancer Res. 56 1996 2960 2963